Skip to main content
SpringerLink
Log in

Size, edge, and stage of NSCLC determine the release of CYFRA 21-1 in bloodstream

  • original article
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Summary

Background

The computed tomography (CT) is the “golden standard” for the assessment of lung cancer progression due to its ability to clearly display the radiomorphologic characteristics. As lung cancer mortality is very high, more comprehensive approaches may be needed for its earlier diagnosis. The research hypothesis was to investigate the relation between the CT morphologic characteristics (size, stage, and edges) of pulmonary lesion and the extent of release of a soluble fragment of cytokeratin 19 being a part of the cytoskeleton of lung epithelial cells.

Methods

This is a retrospective study including 246 pulmonary lesions being diagnosed and subsequently treated at the University Hospital Centre Zagreb, Croatia. The information about the relevant clinical, radiological, and laboratory facts was collected at the time of diagnosis in 164 NSCLC patients, 52 patients with pulmonary metastases, and 30 benign cysts. CYFRA 21-1 was determined by electrochemiluminescence immunoassay. The nonparametric statistical methods were applied.

Results

There was a positive correlation between the size and CYFRA 21-1 in NSCLC unlike metastases or cysts (p = 0.0001). The highest values of CYFRA 21-1 were seen in advanced stages of NSCLC and lesions with spiculated edges.

Conclusions

The level of CYFRA 21-1 positively correlates with the greatest size of NSCLC measured by CT. The differences in CYFRA 21-1 according to TNM classification are significant (p = 0.0001): higher values were observed in advanced stages and with tumors having spiculated, lobulated, and poorly defined edges. The combination of CYFRA 21-1 and CT may help articulate the malignancy of pulmonary lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Globocan.iarc.fr (homepage on the internet). Lyon: International Agency for Research on Cancer; 2010 (accessed and cited 23 March 2012). www.globocan.iarc.fr.

  2. Hzjz.hr (homepage on the internet). Zagreb: Croatian Institute for Public Health. Croatian Cancer Registry (updated 12 October 2012, accessed and cited 25 October 2012). http://www.hzjz.hr/rak/novo.htm.

  3. Kent MS, Port JL, Altorki NK. Current state of imaging for lung cancer staging. Thorac Surg Clin. 2004;14:1–13.

    Article  PubMed  Google Scholar 

  4. Verschakelen JA, Bogaert J, De Wever W. Computed tomography in staging for lung cancer. Eur Respir J Suppl. 2002;35:40S–8S.

    Article  CAS  PubMed  Google Scholar 

  5. Schafer-Prokop C, Prokop M. New imaging techniques in the treatment guidelines for lung cancer. Eur Respir J. 2002;35(Suppl.):71S–83S.

  6. Verschakelen JA, De Wever W, Bogaert J, Stroobant S. Imaging: staging of lung cancer. Eur Respir Monogr. 2004;30:214–44.

    Google Scholar 

  7. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of current evidence. Chest. 2003;123(1 Suppl.):137S–46S.

    Article  PubMed  Google Scholar 

  8. Hyer JD, Silvestri G. Diagnosis and staging of lung cancer. Clin Chest Med. 2000;21:95–106.

    Article  CAS  PubMed  Google Scholar 

  9. Goldstraw P. The 7th edition of TNM in lung cancer: what now? J Thoracic Oncol. 2009;4:671–3.

    Article  Google Scholar 

  10. Chen C, Bao F, Zheng H, Zhou YM, Bao MW, Xie HK, et al. Local extension at the hilum region is associated with worse long-term survival in stage I non-small cell lung cancers. Ann Thorac Surg. 2012;93:389–96.

    Article  PubMed  Google Scholar 

  11. Lee C, Byun C, Lee J, Kim D, Cho B, Chung K, et al. The prognostic factors of resected non-small cell lung cancer with chest wall invasion: a retrospective study. World J Surg Oncol. 2012;12:9.

    Article  Google Scholar 

  12. Neralic Meniga I, Kujundzic Tiljak M, Ivankovic D, Aleric I, Zekan M, Hrabac P, et al. Prognostic value of computed tomography morphologic characteristics in stage I non-small cell lung cancer. Clin Lung Cancer. 2010;11:98–104.

  13. Atance-León P, Moreno-Mata N, González-Aragoneses F, Canizares-Carretero MÁ, García-Jiménez MD, Genovés-Crespo M, et al. Multicenter analysis of survival and prognostic factors in pathologic stage I non-small cell lung cancer according to the new 2009 TNM classification. Arch Bronconeumol. 2011;47:441–6.

    Google Scholar 

  14. Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest. 2002;122:1037–57.

    Article  PubMed  Google Scholar 

  15. Pujol JL, Boher JM, Grenier J, Quantin X. CYFRA 21-1, neuron-specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients. Lung Cancer. 2001;31:221–31.

    Article  CAS  PubMed  Google Scholar 

  16. Molina R, Filella X, Augé JM, Fuentes R, Bover I, Rifa J, et al. Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factors. Tumor Biol. 2003;24:209–18.

    Article  CAS  Google Scholar 

  17. WMA Declaration of Helsinki. Ethical principles for medical research involving human subjects (Internet, accessed and cited 28 May 2013). http://www.wma.net/en/30publications/10policies/b3/.

  18. Silvestri GA, Lenz JE, Harper SN, et al. The relationship of clinical findings to CT scan evidence of adrenal gland metastases in the staging of bronchogenic carcinoma. Chest. 1992;102:1748–51.

    Article  CAS  PubMed  Google Scholar 

  19. Pope RJE, Hansell DM. Extra-thoracic staging of lung cancer. Eur J Radiol. 2003;45:31–8.

    Article  PubMed  Google Scholar 

  20. Moll R, Franke WW, Schiller D, Geiger B, Krepler R. The catalogue of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982;31:11–24.

    Article  CAS  PubMed  Google Scholar 

  21. Moll R, Divo M, Langbein L. The human keratins: biology and pathology. Histochem Cell Biol. 2008;129:705–33.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Aktogu S, Yuncu G, Halilcolar H, Ermete S, Buduneli T. Bronchogenic cysts: clinicopathological presentation and treatment. Eur Respir J. 1996;9:2017–21.

    Article  CAS  PubMed  Google Scholar 

  23. McAdams HP, Kirejczyk WM, Rosado-de-Christenson ML, Matsumoto S. Bronchogenic cyst: features with clinical and histopathologic correlation. Radiology. 2000;217:441–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Department for Diagnostic and Interventional Radiology, University Hospital Centre Zagreb, Zagreb, Croatia

    Helga Sertić Milić MD, PhD

  2. Clinical Unit for Molecular Biology and Genetics of Tumors, Clinic for Pulmonary Diseases Jordanovac, University Hospital Centre Zagreb, Jordanovac 104, 10000, Zagreb, Croatia

    Ana Franjević PhD & Gordana Bubanović PhD

  3. Polyclinic Medikol, Zagreb, Croatia

    Ante Marušić MD, PhD & Igor Puljić MD, PhD

  4. Clinical Hospital Dubrava, Zagreb, Croatia

    Igor Nikolić MD, PhD

Authors
  1. Helga Sertić Milić MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ana Franjević PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gordana Bubanović PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ante Marušić MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Igor Nikolić MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Igor Puljić MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ana Franjević PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sertić Milić, H., Franjević, A., Bubanović, G. et al. Size, edge, and stage of NSCLC determine the release of CYFRA 21-1 in bloodstream. Wien Klin Wochenschr 127, 465–471 (2015). https://doi.org/10.1007/s00508-014-0678-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-014-0678-2

Keywords

Search

Navigation